Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.42 |
| ▸ | MAOB | P27338 | 5/20 | 0.42 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9423936 | 0.91 | CYP3A4 (0.51) | SMN1; SMN2CYP3A4NR1I2HRH3MAOB | |
| SCHEMBL5509217 | 0.87 | SMN1; SMN2 (0.64) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL5496214 | 0.86 | SMN1; SMN2 (0.58) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL1074628 | 0.85 | CYP3A4 (0.72) | SMN1; SMN2CYP3A4NR1I2HRH3MAOB | |
| SCHEMBL5499147 | 0.84 | SMN1; SMN2 (0.75) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| Alcohol SCHEMBL15135686 | 0.83 | SMN1; SMN2 (0.64) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL7908974 | 0.83 | CYP3A4 (0.59) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL5494864 | 0.83 | CYP3A4 (0.55) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL79031 | 0.82 | SMN1; SMN2 (0.68) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL | |
| SCHEMBL4254052 | 0.82 | SMN1; SMN2 (0.68) | SMN1; SMN2CYP3A4NR1I2ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371877-B1 | POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, OPTICAL FILM, AND POLYCARBONATE RESIN MOLDED ARTICLE | MITSUBISHI CHEM CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-20260008920-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | TEIJIN LIMITED (JP) | 2026-01-08 | — | — | US | disclosed |
| EP-4667531-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | Teijin Limited (JP) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024150594-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE COMPRISING SAME | 帝人株式会社 | 2024-07-18 | — | — | WO | disclosed |
| WO-2023176397-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | 帝人株式会社 | 2023-09-21 | — | — | WO | disclosed |
| US-11760840-B2 | Thermoplastic resin composition and molded article thereof | TEIJIN LIMITED (JP) | 2023-09-19 | — | — | US | disclosed |
| US-20230159748-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | TEIJIN LIMITED (JP) | 2023-05-25 | — | — | US | disclosed |
| WO-2023281602-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND PRODUCT | 三菱電機株式会社 | 2023-01-12 | — | — | WO | disclosed |
| EP-3409708-B1 | METHOD OF PREPARING POLYCARBONATE RAW MATERIAL, AND METHOD OF PRODUCING POLYCARBONATE | MITSUBISHI CHEM CORP (JP) | 2022-09-28 | — | — | EP | disclosed |
| US-20220243045-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE, AND PRODUCT | MITSUBISHI ELECTRIC CORPORATION (JP) | 2022-08-04 | — | — | US | disclosed |
| US-4171274-A | Alteration of tesselated magnetic particles by fracture | XEROX CORPORATION (US) | 1979-10-16 | — | — | US | disclosed |
| US-4161454-A | Coating magnetite with polyacid | XEROX CORPORATION (US) | 1979-07-17 | — | — | US | disclosed |
| US-RE29961-E | Curable powder coating composition comprising a mixture of an alkoxylated polyamide-aldehyde resin and a polyester resin | INTERNATIONALE OCTROOI MAATSCHAPPIJ OCTROPA B.V. (NL) | 1979-04-10 | — | — | US | disclosed |
| US-4147645-A | STERICALLY HINDERED PHENOL STABILIZER ADDITIVE FOR RESIN | XEROX CORPORATION (US) | 1979-04-03 | — | — | US | disclosed |
| US-4142981-A | TONER COMBINATION FOR CARRIERLESS DEVELOPMENT | XEROX CORPORATION (US) | 1979-03-06 | — | — | US | disclosed |
| US-4126565-A | Toners for color flash fusers containing a permanent colorant and a heat sensitive dye | XEROX CORPORATION (US) | 1978-11-21 | — | — | US | disclosed |
| US-4097620-A | Magnetic toner particle coating process | XEROX CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
| US-4078930-A | ELECTROSTATOGRAPHIC | XEROX CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
| US-4052207-A | XEROGRAPHY, YELLOW MONOAZO DYE | XEROX CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
| US-4035310-A | STYRENE-VINYL, STYRENE-ACRYLATE COPOLYMERS | XEROX CORPORATION (US) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008920-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | NOP2, CCT2, RPL8 | SMN1; SMN2 2344/4885CYP3A4 3180/4885NR1I2 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.